Optimizing Treatment Outcomes in Advanced NSCLC with Concurrent Biomarker Testing - Episode 4

Improving Time-to-Treatment for Patients With Non-Small Cell Lung Cancer

,

The expert panel underscores the critical importance of rapid diagnostic testing and identification of driver alterations to optimize patient outcomes, given the often-narrow therapeutic window for chemotherapy and targeted therapies.

EP. 1: Optimizing NSCLC Patient Outcomes Through Concurrent Biomarker Testing
EP. 2: Concurrent NSCLC Biomarker Testing at Diagnosis
EP. 3: NCCN Guidelines: Optimizing NSCLC Treatment with Concurrent Biomarker Testing
Now Viewing
EP. 4: Improving Time-to-Treatment for Patients With Non-Small Cell Lung Cancer
EP. 5: Biomarker Testing in Early-Stage NSCLC
EP. 6: Reflex Testing for Patients with Suspected Lung Cancer
EP. 7: Challenges of NSCLC Biomarker Testing in Clinical Practice
EP. 8: Overcoming Barriers to NSCLC Biomarker Testing
EP. 9: Key Takeaways for Concurrent Biomarker Testing in NSCLC